CD4 and myeloid sarcoma: Immunopathology of MS has been widely studied, and based on models of experimental autoimmune encephalomyelitis, the concept of MS as an autoimmune disease mediated by CD4 TH1/TH17 cells specific to autoantigens of the CNS (11) has emerged.